Belgium needs full ownership of its biopharma R&D outcomes

EURACTIV - Belgium stands at a defining moment for the future of its biopharma sector. According to a new Deloitte report, 'Belgium's leadership in Biopharma innovation: Time to act now', Belgium needs to take full ownership of the R&D outcomes it generates. Read more

[Getty Images: Suriphon Singha]